DFS
53
6
CTAS
45
2
DG
33
4
MU
44
2
VLO
33
5
BA
35
2
MDLZ
57
2
DHI
39
7
PWR
58
-7
EBAY
44
2
NRG
52
2
EXPD
34
5
UNP
39
4
LLY
65
20
FIS
78
16
HD
46
5
KR
68
5
NI
67
5
IPG
36
5
WAT
49
11
DFS
53
6
CTAS
45
2
DG
33
4
MU
44
2
VLO
33
5
BA
35
2
MDLZ
57
2
DHI
39
7
PWR
58
-7
EBAY
44
2
NRG
52
2
EXPD
34
5
UNP
39
4
LLY
65
20
FIS
78
16
HD
46
5
KR
68
5
NI
67
5
IPG
36
5
WAT
49
11
Financhill
Back

Innate Pharma SA Vs. Argan Industry Stock Comparison

Sell
43

IPHA
Innate Pharma SA

Last Price:
$1.99
Seasonality Move:
-11.27%
Buy
67

AGX
Argan

Last Price:
$145.99
Seasonality Move:
10.11%
Sell
43
Innate Pharma SA (IPHA) is a Sell

Is Innate Pharma SA a Buy, Sell or Hold?

  • The current Innate Pharma SA [IPHA] share price is $1.97. The Score for IPHA is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • IPHA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Argan (AGX) is a Buy

Is Argan a Buy, Sell or Hold?

  • The current Argan [AGX] share price is $146.00. The Score for AGX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • AGX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

IPHA Stock Price Chart

What is Innate Pharma SA's stock price today?

  • The Innate Pharma SA share price today is $1.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IPHA is experiencing slight selling pressure.

AGX Stock Price Chart

What is Argan's stock price today?

  • The Argan share price today is $146.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AGX is experiencing slight selling pressure.

IPHA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 53.31 Buy
Chaikin Money Flow: -1435 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.82 - 2) Buy
Bollinger Bands (100): (1.66 - 2.14) Buy

AGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.93 Buy
Relative Strength Index (14 RSI): 58.31 Buy
Chaikin Money Flow: -160376 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (120.09 - 141.61) Buy
Bollinger Bands (100): (125.81 - 158.27) Buy

IPHA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.88 Buy
20-day SMA: 1.88 Buy
50-day SMA: 1.99 Sell
200-day SMA: 2 Sell
8-day EMA: 1.9 Buy
20-day EMA: 1.9 Buy
50-day EMA: 1.93 Buy
200-day EMA: 2.04 Sell

AGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.98 Buy
20-day SMA: 133.52 Buy
50-day SMA: 132.82 Buy
200-day SMA: 119.02 Buy
8-day EMA: 142.83 Buy
20-day EMA: 136.24 Buy
50-day EMA: 134.76 Buy
200-day EMA: 119.71 Buy

Innate Pharma SA Earnings Growth & IPHA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Argan Earnings Growth & AGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, an increase next quarter of $0.13 per share, an increase this year of $2.73 per share, and an increase next year of $0.72 per share.

Innate Pharma SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Argan Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):